000			01696 a2200517 4500
005			20250513114410.0
264		0	_c19970917
008			199709s 0 0 eng d
022			_a0961-2033
024	7		_a10.1177/096120339700600307 _2doi
040			_aNLM _beng _cNLM
100	1		_aMartin, F
245	0	0	_aSide-effects of intravenous cyclophosphamide pulse therapy. _h[electronic resource]
260			_bLupus _c1997
300			_a254-7 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAlopecia _xchemically induced
650	0	4	_aAutoimmune Diseases _xdrug therapy
650	0	4	_aConnective Tissue Diseases _xdrug therapy
650	0	4	_aCyclophosphamide _xadministration & dosage
650	0	4	_aDeath, Sudden
650	0	4	_aDrug Administration Schedule
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunocompromised Host
650	0	4	_aImmunosuppressive Agents _xadministration & dosage
650	0	4	_aIncidence
650	0	4	_aInfections _xepidemiology
650	0	4	_aLupus Erythematosus, Systemic _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMultiple Sclerosis _xdrug therapy
650	0	4	_aNeoplasms _xchemically induced
650	0	4	_aNeutropenia _xchemically induced
650	0	4	_aStomatitis _xchemically induced
650	0	4	_aTreatment Outcome
650	0	4	_aVasculitis _xdrug therapy
700	1		_aLauwerys, B
700	1		_aLefèbvre, C
700	1		_aDevogelaer, J P
700	1		_aHoussiau, F A
773	0		_tLupus _gvol. 6 _gno. 3 _gp. 254-7
856	4	0	_uhttps://doi.org/10.1177/096120339700600307 _zAvailable from publisher's website
999			_c9086865 _d9086865